LISAvienna: Read our newsletter now

Today, we list headlines published by AOP Orphan, cogvis, enGenes, Eucodis Bioscience, F2G, Hookipa Pharma, IMBA, IMP, Ingenetix, Lexogen, MedUni Wien, Nabriva, PhagoMed, Phenaris, Takeda, Valneva and the Vienna BioCenter. In addition, we update you on funding opportunities and virtual events.

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.